CHPT vs LAB · rev $417.1M vs rev $174.4M
ChargePoint Holdings Inc (CHPT) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
ChargePoint Holdings Inc (CHPT) is a specialty retail company listed on NYSE.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CHPT revenue for 2025-01-31 was $417.1M. Net income was -$277.1M. Revenue was down 17.7% from 2024-01-31 to 2025-01-31. CHPT currently screens at market cap $199.2M.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CHPT currently screens at market cap $199.2M. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CHPT and LAB stock pages for the full models.
Not investment advice.